Maria Gilleece

Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study

Adrian Bloor, Amit Patel, James E. Griffin et al. · Nature Medicine · 2020 · 289 citations

Life Sciences, Biotechnology, Translational Sciences +14

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

Alexandros Spyridonidis, Myriam Labopin, Bipin N. Savani et al. · Bone Marrow Transplantation · 2020 · 203 citations · Full text

Medicine, Oncology, Stem Cell Transplantation +14

Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

Charles Craddock, Aimee Jackson, Justin Loke et al. · Journal of Clinical Oncology · 2020 · 165 citations · Full text

Medicine, Oncology, Chemotherapy +14

Human Non-Germinal Center B Cell Interleukin (IL)-12 Production Is Primarily Regulated by T Cell Signals CD40 Ligand, Interferon γ, and IL-10: Role of B Cells in the Maintenance of  T Cell Responses

Joachim L. Schultze, Sabine Michalak, Joel Lowne et al. · The Journal of Experimental Medicine · 1999 · 135 citations · Full text

Life Sciences, Immunology, Microbiology +17

Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation

Maria Gilleece, Myriam Labopin, Ibrahim Yakoub‐Agha et al. · American Journal of Hematology · 2018 · 125 citations · Full text

Medicine, Hematology, Oncology +16